期刊文献+

骨生化指标联检在骨质疏松诊疗中的临床意义 被引量:7

Clinical Significance of Biochemical Markers in Treatment of Osteoporosis
下载PDF
导出
摘要 目的:探讨25-羟基维生素D(25-OH-VD)与抗酒石酸酸性磷酸酶(TRACP-5b)联检在骨质疏松诊疗中的意义。方法:使用英国IDS公司的试剂盒,采用酶联免疫法(ELISA),对328例中老年患者血清做25-OHVD与TRACP-5b的检测及分析。结果:25-OH-VD指标均偏低,男性(16.18±6.77)ng/ml,女性(15.16±7.87)ng/ml,男女间差异无统计学意义(P>0.05);TRACP-5b水平女性高于男性,女性(5.71±2.46)u/L,男性(4.98±1.61)u/L,差异具有统计学意义(P<0.05)。25-OH-VD与TRACP-5b两项指标比较,相关系数(r)=-0.121,两指标呈负相关,有统计学意义(P<0.05)。结论:25-OH-VD与TRACP-5b联检对骨质疏松诊疗具有重要的参考价值。 Objective To discuss the meaning of 25-OH-VD and TRACP-Sb insepction in the diagnosis and treatment of osteoporo- sis. Methods Use English ISD company's reagent kit on 325 elderly patients serum 25-OH-VD, TRACP-Sb detection by ELISA. Analy- sis was made based on the results. Results The concentration of 25-OH-VD were on the low levels, male 15.18 ± 6.77ng/ml, female 15.16 ± 7.87ng/ml. Male and female had no difference ( P 〉 0.05) ; The level of TRACP-Sb in female group was statistically higher than that in male group. The former was 5.71±2.46u/ml, the latter was 4.98 ±1.61u/ml, and the difference was statistically significant (P 〈0.05). The two indicators of 25-OH-VD and TRACP-Sb were compared, with statistical significance (P 〈0.05) ,correlation coeffi- cient = -0. 121 ,two negatively related. Conclusion 25-OH-VD and TRACP-Sb inspection on osteoporosis diagnosis has important ref- erence value.
出处 《放射免疫学杂志》 CAS 2012年第2期185-187,共3页 Journal of Radioimmanology
关键词 血清抗酒石酸酸性磷酸酶5b 25-羟基维生素 D 标志物 骨质疏松 tartrate resistand acid phosphatase 5b, 25-hybroxyvitamin D, marker, osteoporsis
  • 相关文献

参考文献7

  • 1张军芳,蒋飞霞,徐裔婷.骨代谢生化标志物与骨质疏松症研究进展[J].中国热带医学,2009,9(3):569-570. 被引量:21
  • 2Delmas PD,Seeman E. Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with antiresorptive therapy[J].Bone,2004.599-604.
  • 3肖恩,司良毅,孟萍.血清抗酒石酸酸性磷酸酶5b测定在老年人中的临床应用[J].重庆医学,2008,37(2):159-160. 被引量:17
  • 4Halleen JM. Tartrate resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption[J].Anticancer Research,2003,(2A):1027.
  • 5Hallen JM,Tiitinen SL,Ylipahkala H. Tartrate resistant acid phosphatase 5b(TRACP 5b) as a marker of bone resorption[J].Clinica y Laboratorio,2006,(9-10):499.
  • 6Bord S,Horner A,Beavan S. Estrogen receptors and β are differential expressed in developing human bone[J].Journal of Clinical Endocrinology and Metabolism,2001,(05):2309-2314.
  • 7Levin ER. Cellular functions of plasma membrane estrogen receptors[J].Steroids,2002,(06):471-475.

二级参考文献29

共引文献35

同被引文献65

  • 1王景,蒋欣峰,李小梅,洪苑.绝经后老年骨质疏松患者血清脂联素与骨代谢生化指标的相关性[J].中国老年学杂志,2015,35(2):360-361. 被引量:20
  • 2涂平生,黄自为,曾颖,徐杰.依普黄酮对绝经后妇女骨质疏松性骨折愈合的临床研究[J].中国药物与临床,2005,5(3):190-191. 被引量:6
  • 3Bai AP, Ouyang Q, Hu RW. Basic research on inflammatory bowel disease in China[J]. J Dig Dis,2007,8(4) :194-197.
  • 4Holiek MF. Vitamin D Deficiency[J]. N Engl J Med,2007, 357 (3) :266-281.
  • 5KellyP, SuibhneTN, O'MorainC, etal. VitaminD status and eytokine levels in patients with Crohn's disease[J]. Int J Vitam Nutr Res, 2011,81 (4) :205-210.
  • 6Zhang C, Zhao L, Ma L, et al. Vitamin D status and expression of vitamin D receptor and LL-37 in patients with spontaneous bacterial peri- tonitis E J ]. Dig Dis Sei, 2012,57 ( 1 ) : 182-188.
  • 7Joseph A J, George B, Pulimood AB, et al. 25 (OH) vitamin D level in Cmhn's disease: association with sun exposure & disease activity EJ]. Indian J Med Res,2009 ,130(2) :133-137.
  • 8Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice I J ]. Endocr Rev,2008 , 29(6) :726-776.
  • 9Ananthakrishnan AN, Khalili H, Higuehi LM, et al. Higher pre- dicted vitamin D status is associated with reduced risk of Crohn's disease J ]. Gastroenterology, 2012 , 142 (3) :482-489.
  • 10Demers LM.New biochemical markers for bone dis ease:is a break through[J].Clin Chem,1992,38(11):2169-2170.

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部